Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Launch of a new service for developers and adopters of AI and digital technologies in England

15 Mar 2023

The creation of a new multi-agency advisory service for developers and adopters of Artificial Intelligence (AI) and other digital technologies in healthcare started in 2021, funded by NHS AI Lab. Four organizations collaborate in this service: the National Institute of Health and Care Excellence (NICE), the Care Quality Commission (CQC), the Medicines and Healthcare Products Regulatory Agency (MHRA), and the Health Research Authority (HRA).

In March 2023, the public beta website “AI and Digital Regulations Service” became available. For now, it is focused on the developer pathway; the adopter pathway will be added later in 2023. The following technologies are considered:

  • Software as Medical Device (SaMD);
  • Digital technology;
  • AI, or data-driven technology.

The service maps out the regulatory and Health Technology Assessment pathway for AI and digital technologies and helps users understand and navigate the pathway more effectively. Guidance is provided at each stage of the pathway and divided into two types: required (‘must do’) and best practice (‘should do’). Regular updates will be made to account for new developments in this area.

See more details here and here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.